interaction with junctional adhesion molecule (JAM)-1, -2, and -3 (7, 8, 22, 42) . As a result of alternative splicing, several isoforms of Pard3a exist. They all share a common NH 2 -terminal region and can easily be distinguished by their molecular mass (100, 150, and 180 kDa) (28) . All isoforms contain the three PDZ domains. The 100-kDa isoform, however, lacks the aPKC-binding domain. The expression pattern of the isoforms varies throughout different tissues, and the biological function of different isoforms remains to be elucidated (28) .
The Scribble complex, composed of lethal giant larvae (Lgl), discs large (Dlg), and Scribble, localizes to the basolateral domains of the cell membrane (2, 30) and plays a role in the regulation of vesicle trafficking, signal transduction, and cytoskeletal remodeling (18) .
The third polarity complex, which is essential for apicobasal polarity, is the Crumbs complex, composed of Crumbs, protein associated with Lin-7 1 (PALS1), and PALS1-associated tight junction (PATJ) (37) . The localization at the apical domain is required to connect this complex with the tight junctions.
Cell polarity has been extensively studied in epithelial cells of the kidney. While apico-basal localization of transporters, channels, and growth factors is essential for reabsorptive and secretory functions of kidney tubular cells (45) , the mechanisms that control cell polarity signaling in podocytes are less well understood. Recent studies from several laboratories indicated that the aPKC-Par complex localizes to the slit diaphragm of podocytes and showed an essential role for aPKC activity in the development and maintenance of the glomerular filtration barrier (11, 12, 15, 17) .
Podocytes are highly polarized cells and an essential component of the glomerular filtration barrier of the kidney. They enwrap the glomerular capillaries with their foot processes and are part of the three-layered filtration barrier, built out of fenestrated endothelium, basement membrane, and the podocytes (33) . Adjacent podocytes are connected through a unique cell-cell contact, the slit diaphragm (33) . This intercellular structure not only consists of both tight and adherens junction proteins, like JAM-2 and occludin (9) , and catenins and cadherin (36) , but also the Neph-Nephrin complex, which directly interacts with Par3 via the first PDZ domain (11, 15) .
Polarity signaling and, in particular, aPKC-mediated signaling events have a great impact on podocyte survival and slit diaphragm integrity. There are also two isoforms of aPKC, aPKC-and -, which have high amino acid sequence similarities, but are encoded on two different genes (41) . Genetic deletion of aPKC-in podocytes results in severe glomerular disease with premature death after 4 -6 wk (15, 17) , while genetic depletion of aPKC-did not cause any glomerular disease (12) . In contrast to the well-established role of aPKCmediated signaling in podocytes, the contribution of associated Par proteins is less clear. Although cell biological data suggested that the aPKC-Par complex may have a typical conserved role also in podocytes (11) , this has not been tested in vivo. To clarify the contribution of Par proteins to the aPKCPar polarity signaling complex at the filtration barrier of the kidney, we generated a podocyte-specific Par3a knockout (KO) mouse model. Surprisingly, these data demonstrate that the function of the aPKC-Par complex in podocytes is not affected by the lack of Par3A and strongly suggest the existence of a podocyte-specific composition of the aPKC-Par complex associated with the slit diaphragm. Table 1 for list of antibodies used. Oligonucleotide. See Table 2 for list of oligonucleotides used. Transgenic mouse models. To generate a podocyte-specific Par3A KO (Par3A pko ), mice with a floxed exon 6 in the Pard3a gene were generated. Generation of mice carrying the conditional KO allele was done by Taconic Biosciences. To achieve a podocyte-specific KO, the floxed Pard3a mice were mated to NPHS2.Cre mice (31) . For the isolation of primary podocytes, Par3A pko mice were mated to R26mTmG mice (32) .
METHODS

Antibodies. See
We used mice from both sexes for the described studies. All animals were on a mixed C57/Bl6 and CD-1 background. The mouse holding was done in the University of Cologne animal facility, according to standardized specific pathogen-free conditions. The experimental protocol was examined and approved by the LANUV NRW (Landesamt für Natur, Umwelt und Verbraucherschutz Nordrhein-Westfalen/State Agency for Nature, Environment and Consumer Protection North Rhine-Westphalia).
Isolation of primary podocytes. To isolate primary podocytes, Par3A flox/flox , R26mTmG ϩ/WT , and NPHS2.Cre ϩ/WT mice were killed, and kidneys were used for glomerular preparation, as previously described (3). The glomeruli were digested, and the single-cell suspension was used for FAC sorting.
RNA preparation and quantitative PCR. The RNA from primary podocytes (green fluorescent protein-positive), as well as immortalized mouse podocytes, was isolated with the RNeasy Kit from Qiagen. Quantitative PCR (qPCR) was performed with SYBR Green qPCR mix from Applied Biosystems. Used primers are listed in Table 2 .
Urinary analysis. Measurement of the urinary albumin levels was performed with a mouse albumin ELISA kit (ICL/Dunn Labortechnik, Asbach, Germany). Creatinine levels were measured with a urinary creatinine kit (Biomol, Hamburg, Germany).
BSA overload study. To induce glomerular disease, we injected bovine serum albumin (BSA fraction V) (Gerbu, Heidelberg, Germany) into the peritoneal cavity of Par3A pko and Par3A fl/fl mice. BSA was dissolved in phosphate-buffered saline and sterile filtered to get a final concentration of 500 mg/ml. Injections of 10 mg/g body weight BSA were performed in the morning. Animals were injected for 5 days and either euthanized at day 5 or monitored until day 12 and day 19. LPS study. Lipopolysaccharide LPS was injected into the peritoneal cavity of Par3A pko and Par3A fl/fl mice. LPS was dissolved in NaCl and sterile filtered with a final concentration of 0.25 /l. Injections were performed in the morning with 20 g/g body weight LPS (29) . Before injection, urine was collected. The animals included in the study were from both sexes and between 12 and 24 mo old. Twentyfour hours after the LPS injection, mice were killed, and urine was collected.
Histological analysis on mouse tissue. Mice were perfused with phosphate-buffered saline, and kidneys were either fixed in 4% paraformaldehyde overnight or frozen in Tissue-Tek OCT compound (Sakura, Leiden, the Netherlands). Paraformaldehyde-fixed kidneys were embedded in paraffin and used for cutting 2-m thick sections. To study morphological changes, we performed a periodic-acid staining. For immunofluorescence analysis, frozen kidney sections (4 m) were used. After fixation with paraformaldehyde, sections were blocked with 5% normal donkey serum in phosphate-buffered saline with 0.1% Triton X and subsequently incubated with primary and secondary antibodies. Mounting was done with Prolong Gold antifade with DAPI (Invitrogen, Carlsbad, CA). All images were taken with an Axiovert 200 M microscope/EC Plan-Neofluar ϫ63/1.30 water immersion objective (all from Carl Zeiss MicroImaging). Images were further processed with ImageJ/Fiji Software and Photoshop CS4 version 11.0.
Electron microscopy. Mice were perfused with electron microscopy fixation buffer (4% paraformaldehyde and 2% glutaraldehyde in 0.1 M sodium cacodylate, pH 7.4). The samples were postfixed for 2 wk more in the same buffer at 4°C. The kidneys were osmicated with 1% OsO 4 in 0.1 M cacodylate and dehydrated in a graduated ethanol series. Epon infiltration and flat embedding were performed following standard procedures. Semithin sections (0.5 m) were stained with toluidine blue. Thirty-nanometer-thick sections were cut with an Ultracut UCT ultramicrotome (Reichert). Afterwards, the sections were stained with 1% aqueous uranylic acetate and lead citrate. Samples were studied with a Zeiss EM 902 electron microscope (Zeiss, Oberkochen, Germany) and Zeiss EM 109 electron microscope (Zeiss). Immunogold labeling was performed with fixed mouse kidney samples. These samples were embedded in Lowicryl K4M resin (Electron Microscopy Sciences, Hatfield, PA), and ultrathin Table 2 . Oligonucleotides sections were labeled by an indirect immunogold protocol, as described previously (16) . Images were further processed with Fiji using the enhance local contrast (CLAHE) algorithm (47) . Cell culture. Immortalized mouse podocytes (39) were cultured with RPMI-1640 medium (Sigma-Aldrich, St. Louis, MO) with 10% fetal bovine serum, 5% sodium pyruvate solution 100 mM (SigmaAldrich, St. Louis, MO), and 5% HEPES buffer solution 1 M (Life Technologies, Carlsbad, CA). Undifferentiated cells were cultured at 33°C and with 2.5-l murine IFN-␥ (Provitro, Berlin, Germany). For differentiation, cells were grown at 37°C for 14 days without IFN-␥.
Western blot. Immortalized mouse podocytes were harvested and lysed in 100 l 1% Trition X-100 buffer (20 mM Tris·HCl, pH 7.5, 50 mM NaCl, 50 mM NaF, 15 mM Na 4P2O7) and 1 mM PMSF and 2 mM Na 3OV4. After incubation on ice for 15 min and centrifugation (14,000 g, 4°C, 15 min), the supernatant was used for further analysis. Lysates were diluted with a 2ϫ SDS-PAGE buffer. Proteins were then separated by SDS-PAGE, blotted on polyvinylidene difluoride membranes, and visualized with chemiluminescence after antibody incubation.
Statistical analysis. All results are expressed as means Ϯ SE. Statistical significance was evaluated using GraphPad Prism version 6 for Windows (GraphPad Software, San Diego, CA). For two groups, unpaired Student's t-test was performed. For several groups, one-way ANOVA, combined with Dunnett's multiple-comparison test, and, for two independent variables, two-way ANOVA combined with Tukey's or Bonferroni's multiple-comparison test, was applied, and a P value Ͻ 0.05 was considered significant.
RESULTS
Generation of a novel Par3a conditional KO mouse model.
To study the contribution of Par proteins to the aPKC-Par polarity signaling complex in podocytes, we generated a podocyte-specific Pard3a KO mouse model. First, we generated mice in which exon 6 of the Pard3a gene was floxed, resulting in a frameshift and premature stop codon upon Cre-mediated recombination (Fig. 1A) . To achieve an exclusive genetic deletion of Pard3a in podocytes, we crossed these Par3A fl/fl mice with NPHS2.Cre mice (31) . PCR on glomerular DNA as template using specific primers confirmed the genetic recombination of exon 6 (Fig. 1B) . Gene deletion efficiency was further validated by analyzing Pard3a mRNA expression from isolated podocytes by qPCR and by indirect immunofluorescence to assess Par3A protein expression (Fig. 1, C and D) . We observed a loss of both Par3A mRNA and protein expression confirming efficiency of Cre-mediated gene deletion in podocytes.
Loss of Par3A in podocytes does not cause glomerular disease. Surprisingly, mice of all genotypes were born following Mendelian rules, and monitoring Par3A pko animals and their littermate controls for 1.5 yr did not reveal any obvious differences in development and life expectancy ( Fig. 2A) . To analyze the effects of a podocyte-specific Pard3a gene deletion in greater detail, we performed histological analyses after 10 wk, 6 mo, and 1.5 yr. Par3A pko mice did not develop glomerulosclerosis at any time point studied (Fig. 2, B and C) . Additional electron microscopy studies did not reveal any changes in the interdigitating foot process pattern nor the slit diaphragm integrity (Fig. 2D ). There were no differences in the urinary albumin-to-creatinine ratio between Par3A pko mice and their littermate controls (Fig. 2E) . Taken together, inactivation of Par3A in podocytes does not result in any obvious glomerular disease.
Par3A function is dispensable in states of glomerular disease. As the loss of Par3A in podocytes did not affect glomerular function, we then assessed the role of Par3A on induction of glomerular disease. We utilized the BSA overload model (Fig. 3A) to induce a reversible glomerular injury, which is characterized by loss and subsequent reformation of podocyte foot processes (35) . Both control and Par3A pko animals showed a significant increase in albuminuria after 5 days of daily BSA administration into the peritoneal cavity, indicating a defective glomerular filtration barrier (Fig. 3B) . Although we observed a slight trend toward increased levels of albuminuria in Par3A pko mice, this did not reach statistical significance. Ten days after the last injection, both groups recovered similarly and showed normal urinary albumin-to-creatinine ratios. Histological analyses at the time of death did not show any obvious changes in glomerular structure, neither in Par3A pko nor in control animals (Fig. 3C) . To further substantiate these findings, we performed a second podocyte disease model by injecting LPS intraperitoneally (29, 35) . After 24 h, both Par3A pko and control mice developed significant albuminuria (Fig. 3D) . However, there were no statistically significant differences between Par3A pko and wild-type controls. Taken together, these data confirm the observation that Par3A is dispensable for podocyte function.
Par3B expression at the slit diaphragm. The lack of any glomerular phenotype in Par3A pko mice challenges our current view on Par3A-mediated aPKC signaling at the slit diaphragm. As initial studies on Par3 function in podocytes (11) did not distinguish between Par3A, its various isoforms, or Par3B, we used publicly available mRNA sequencing data (24) from primary mouse podocytes to gain insights into the expression pattern of Pard3a and -b in these cells. These data revealed that podocytes express high levels of Pard3b, which is 32-fold higher compared with Pard3a (24) . Analyzing Par3B expression levels in cultured mouse podocytes also revealed a significant increase of Par3B during differentiation, both on mRNA as well as on protein levels (Fig. 4, B and C) . To study the cellular localization of Par3B in the glomerulus, we performed immunofluorescence stainings on mouse kidney sections. We observed a slit diaphragm pattern for Par3B similar to podocin (Fig. 4D) . Additional immunogold labeling experiments confirmed localization of Par3B at the slit diaphragm and also revealed localization at basal domains of the foot processes (Fig. 4E) . In addition, Par3B mRNA levels increase significantly in Par3A pko primary podocytes compared with Par3A fl/fl control cells (Fig. 4F) . Taken together, these data show that Par3B and not Par3A is the predominant Par3 protein in podocytes and suggest a functional role for Par3B at the slit diaphragm. Fig. 3 . Par3A function is dispensable in states of glomerular disease. A: study protocol of the BSA overload model to induce transient glomerular injury. Animals were injected on 5 consecutive days with 10 mg/g body weight (BW) BSA and killed 14 days after the last injection. B: urinary albumin-tocreatinine ratio revealed a significant increase of albumin after 5 days of BSA injection in Par3A pko mice and the littermate controls compared with the baseline levels at day 1. *P Ͻ 0.05 and ****P Ͻ 0.001 (two-way ANOVA and Tukey's multiple-comparison test). The differences between Par3A pko and control mice at day 5 were not statistically significant (two-way ANOVA and Tukey's multiple-comparison test). C: PAS stainings at days 1 and 5 did not show any morphological differences between Par3A pko mice and their littermate controls (scale bar ϭ 100 m and 50 m). D: urinary albumin-tocreatinine ratios demonstrate a significant increase in urinary albumin levels 24 h after LPS injection in Par3A pko and control mice. *P Ͻ 0.05 and **P Ͻ 0.01 (two-way ANOVA and Tukey's multiple-comparison test). There was no difference between Par3A pko mice and the littermate controls after 24 h (two-way ANOVA and Tukey's multiple-comparison test).
DISCUSSION
During the last decade, podocyte damage has been accepted to be one of the major causes of albuminuria and glomerular kidney diseases. Several pathways were discovered, which impact on podocyte maintenance and slit diaphragm integrity, including aPKC polarity signaling (4). However, the guidance cues linking aPKC to the slit diaphragm are not well understood. Here we studied the functions of the polarity protein Par3A in podocytes, a major component of the Par complex and a potential scaffold protein for aPKC. This complex is of particular interest, as it is known to directly interact with Nephrin and Neph1, two core components of the slit diaphragm (11, 15) .
Hirose et al. (14) generated a Pard3a flox/flox mouse by targeting exon 3. While the authors report on a severe epicardial phenotype, the gene KO was incomplete, and not all epithelial cells were affected by the Pard3a gene KO (14) . Duncan et al. (5) described three additional exons 3b, 15b, and 20b in the Pard3a gene. Exon 3b harbors a second ATG, which is in frame and leads to expression of two Par3A variants, even if exon 3 is knocked out. To circumvent these limitations, we generated a novel Pard3a podocyte-specific KO mouse model in which we targeted exon 6 with loxP elements to achieve a frameshift and degradation of the mRNA upon Cre-mediated recombination in podocytes (31) . Even though we could clearly confirm KO efficiency and loss of Par3A mRNA and protein expression in podocytes, the Par3A pko mice were as viable, fertile, and developed as their littermate controls. Even challenging Par3A pko mice did not show any signs of a chronic glomerular disease in the Par3A KO mice. However, certain limitations apply that need to be discussed. Due to technical limitations, we cannot exclude a potential role of Par3A during early stages of glomerular development. Expression of the Cre recombinase is under the control of a hNphs2 promoter fragment and becomes active in late capillary loop stages (31) . However, Par3A and aPKC-are already expressed during early developmental stages at apical regions and translocate to basal parts during development (17) . Of note, the published podocyte-specific aPKC-KO phenotype, which presented with severe glomerular disease within 4 wk of life, was the result using the same Cre driver mouse line (17) . Taken together, as we did not observe any glomerular phenotype after genetic deletion of Pard3a, we conclude that Par3A function is dispensable for podocyte maintenance and function. Based on the published mRNA sequencing data sets from isolated podocytes, Par3B is the most abundant Par3 protein in podocytes, which might rescue for the loss of Par3A or is the predominant Par3 protein per se (24) . Par3B is a Par3A homolog first described by Gao et al. (10) and Kohjima et al. (26) in 2002. The murine Pard3b gene is located on chromosome 1 and contains 23 exons. Given the high amino acid identity between the conserved regions, it was named Par3-L (Par3-like) or Par3B (10, 26) . Par3B is expressed in several tissues, with the highest levels in lung, skeletal muscle, and kidney (10, 26) . Although Par3B displays marked differences in protein domain structure compared with Par3A, there is a high identity between the conserved PDZ regions. Nevertheless, Par3B does not interact with aPKC, while interaction with Par6 is still under discussion (10, 26) . Cell-cell contact localization of Par3B could be demonstrated by costaining with the tight junction marker zonula occludens-1, although a cytoplasmic localization was also observed (10, 26) . In murine immortalized podocytes, we observed a similar membrane and cytoplasmic localization pattern. In this study, we show that Par3B mRNA and protein levels increase during differentiation in immortalized mouse podocytes. In addition, we provide evidence that Par3B exhibits a slit diaphragm-like localization pattern. Given its high expression in podocytes, its localization to the slit diaphragm, and its upregulation in the absence of Par3A, we hypothesize that Par3B might either compensate for the loss of Par3A and/or be the dominant Par3 protein with regard to Par3 function in general. Although Par3B seems not to interact with aPKC, one could easily envision that it might still be in a complex with aPKC through direct interaction with Par6. Furthermore, Par3B has an impact on mammary stem cell maintenance and is, in contrast to Par3A, interacting with the tumor suppressor protein Lkb1, which leads to inhibition of Lkb1 kinase activity (20) . This unique function of Par3B suggests that there are additional Par3B exclusive functions, which could also apply for podocytes.
Another explanation for the lack of any glomerular phenotype could lie in a high redundancy between the polarity proteins from different complexes, which could result in strong compensatory effects. Interestingly, not only does the loss of Par3A in podocytes lack a glomerular phenotype, but also the Scribble KO in mice does not induce glomerular disease (13) , although its presence is needed for pronephros development in zebrafish (13, 40) . There is only a single report in zebrafish on Crumbs function in podocytes, showing that the presence of Crumbs is essential for podocyte formation and maintenance (6). Ebarasi et al. (6) could clearly demonstrate that, in Crumbs morphants, the podocyte foot process pattern was disorganized and the SD was lost. As podocytes have only one cell-cell contact, one might speculate that the three major polarity complexes (Par, Scribble, and Crumbs complex) interact in a much higher fashion with each other compared with other epithelial cells. As Par6 can directly interact with Lgl and PALS1, the aPKC-Par6 complex might localize to the slit diaphragm via interaction with the Scribble or Crumbs complex and not via Par3A (27, 46) . This might lead to strong compensation effects, when deleting one of the polarity proteins. Clearly, further experiments are required to study the role of Par3B in podocytes and, in particular, at the slit diaphragm, and whether it is regulating aPKC function.
In conclusion, our data shows that Par3A is dispensable for podocyte maintenance and function. Given the strong effect of aPKC polarity signaling, podocytes might have evolved strong compensatory pathways to cope with loss of one of the polarity proteins to ensure podocyte function. We, therefore, hypothesize a compensatory mechanism either through a potential novel slit diaphragm protein, Par3B, or high redundancy of the other polarity proteins, like Lgl or PALS1.
